Get the Stockscreener App
2.12
0.93%
-0.02
After Hours:
2.10
-0.02
-0.94%
Avalon Globocare Corp stock is traded at $2.12, with a volume of 8,032.
It is down -0.93% in the last 24 hours and down -10.92% over the past month.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
See More
Previous Close:
$2.14
Open:
$2.14
24h Volume:
8,032
Relative Volume:
0.11
Market Cap:
$8.21M
Revenue:
$1.39M
Net Income/Loss:
$-20.34M
P/E Ratio:
-0.1834
EPS:
-11.5573
Net Cash Flow:
$-5.77M
1W Performance:
-4.50%
1M Performance:
-10.92%
6M Performance:
-43.16%
1Y Performance:
-32.27%
1-Day Range:
$2.05
$2.14
1-Week Range:
$2.01
$2.20
52-Week Range:
$1.87
$11.60
Avalon Globocare Corp Stock (ALBT) Company Profile
Name
Avalon Globocare Corp
Sector
Industry
Phone
732-780-4400
Address
4400 ROUTE 9, FREEHOLD
Compare ALBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALBT
Avalon Globocare Corp
|
2.12 | 8.21M | 1.39M | -20.34M | -5.77M | -11.56 |
|
CBRE
Cbre Group Inc
|
152.43 | 45.49B | 39.33B | 1.33B | 1.41B | 4.0485 |
|
CSGP
Costar Group Inc
|
68.81 | 29.52B | 2.92B | 104.20M | -1.70M | 0.2549 |
|
BEKE
Ke Holdings Inc Adr
|
17.05 | 20.12B | 14.28B | 541.49M | 349.77M | 0.4616 |
|
JLL
Jones Lang Lasalle Inc
|
305.09 | 14.41B | 24.68B | 564.70M | 717.70M | 11.63 |
|
CIGI
Colliers International Group Inc
|
159.53 | 8.12B | 4.56B | 154.04M | 198.18M | 3.14 |
Avalon Globocare Corp Stock (ALBT) Latest News
Will earnings trigger a reversal in Avalon GloboCare Corp.July 2025 Fed Impact & Stock Portfolio Risk Management - newser.com
Backtesting results for Avalon GloboCare Corp. trading strategiesQuarterly Profit Report & Long-Term Investment Growth Plans - newser.com
Is now a turning point for Avalon GloboCare Corp.2025 Performance Recap & Fast Momentum Entry Tips - newser.com
What recovery options are there for Avalon GloboCare Corp.July 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com
Quantitative breakdown of Avalon GloboCare Corp. recent move2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Can Avalon GloboCare Corp. stock hit analyst price targetsJuly 2025 Fed Impact & Growth Focused Entry Point Reports - newser.com
What to expect from Avalon GloboCare Corp. in the next 30 daysTrade Analysis Summary & Weekly Stock Breakout Alerts - newser.com
Can a trend reversal in Avalon GloboCare Corp. lead to recoveryJuly 2025 Earnings & Real-Time Sentiment Analysis - newser.com
How Avalon GloboCare Corp. stock compares to industry benchmarksJuly 2025 Decliners & AI Optimized Trading Strategy Guides - newser.com
How hedge fund analytics apply to Avalon GloboCare Corp. stockJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - newser.com
Short interest data insights for Avalon GloboCare Corp.2025 Dividend Review & Technical Buy Zone Confirmation - newser.com
Can Avalon GloboCare Corp. stock sustain market leadershipPortfolio Update Summary & Low Risk High Reward Trade Ideas - newser.com
Applying Elliott Wave Theory to Avalon GloboCare Corp.July 2025 Patterns & Weekly Top Stock Performers List - newser.com
Relative strength of Avalon GloboCare Corp. in sector analysisMarket Trend Report & Fast Moving Stock Trade Plans - newser.com
How Avalon GloboCare Corp. stock benefits from global expansion2025 Market Overview & Real-Time Volume Analysis - newser.com
How to build a custom watchlist for Avalon GloboCare Corp.Earnings Trend Report & Trade Opportunity Analysis Reports - newser.com
How Avalon GloboCare Corp. stock compares to market leadersPortfolio Return Summary & Consistent Growth Equity Picks - Fundação Cultural do Pará
Avalon GloboCare’s (ALBT) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
Avalon Globocare Corp Stock (ALBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.33%
3.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):